Arterial puncture closure using a collagen plug, II. (VasoSealTM)

Cleveland, Greg; Hill, Sam; Williams, Scott G.

doi:10.1053/tvir.2003.36450

Cited by 4 publications

(7 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Since the first generation of the VasoSeal device was approved by the FDA in 1995, there have been a total of four different platforms of VasoSeal which include (1) VasoSeal Vascular Hemostasis Device (VHD), (2) VasoSeal ES (Extravascular Security), (3) VasoSeal Low Profile, and (4) VasoSeal Elite. 17,18 These various platforms are intended to be used for varying diameters of the arterial punctured site. Both VasoSeal Elite and ES utilize a temporary J-shaped locator segment, which is deployed so the collagen plug is deposited on the outer surface of the vessel wall along the puncture tract.…”

Section: Collagen-based Vascular Devicesmentioning

confidence: 99%

“…Numerous clinical series have reported high technical success rates ranging from 90% to 100%. 4,17,18,33,38,47 In patients who received systemic anticoagulation, this device remained efficacious in achieving hemostasis following percutaneous interventions. 17,47,48 Several comparative studies between the VasoSeal device and manual compression demonstrated no differences in the rate of femoral artery pseudoaneurysm or hematoma formation.…”

Section: Clinical Experience With Vascular Closure Devicesmentioning

confidence: 99%

“…4,17,18,33,38,47 In patients who received systemic anticoagulation, this device remained efficacious in achieving hemostasis following percutaneous interventions. 17,47,48 Several comparative studies between the VasoSeal device and manual compression demonstrated no differences in the rate of femoral artery pseudoaneurysm or hematoma formation. 4,17,18,38,47,48 In the early 1990s, multiple randomized studies favored MC over VasoSeal use in patients undergoing PCI.…”

Section: Clinical Experience With Vascular Closure Devicesmentioning

confidence: 99%

See 2 more Smart Citations

Access site management with vascular closure devices for percutaneous transarterial procedures

Bechara

Annambhotla

Lin

2010

Journal of Vascular Surgery

View full text Add to dashboard Cite

The rising numbers in the aging population will undoubtedly lead to a corresponding increase in percutaneous endovascular procedures to address their cardiovascular health issues. With a constant drive to develop innovative treatment methods to achieve improved treatment outcomes while reducing procedural-related complications, endovascular interventionalists have focused on technologies to provide efficient hemostatic control of femoral artery access following percutaneous diagnostic or therapeutic angiographic procedures. Compared with the traditional hemostatic method using manual compression, several arterial closure devices (ACD) have been shown to reduce time of hemostasis, enable early patient ambulation, reduce hospitalization staff use, and improve patient outcome. However, these ACDs have their shortcomings as the interventionalists need to be familiar with these technologies as well as their potential complications. This article provides a comprehensive review of current closure device technologies as well as clinical experiences with these devices. The adjunctive role of these technologies in endovascular aortic aneurysm repair is also discussed.

show abstract

Section: Collagen-based Vascular Devicesmentioning

confidence: 99%

Section: Clinical Experience With Vascular Closure Devicesmentioning

confidence: 99%

Section: Clinical Experience With Vascular Closure Devicesmentioning

confidence: 99%

See 1 more Smart Citation

Access site management with vascular closure devices for percutaneous transarterial procedures

Bechara

Annambhotla

Lin

2010

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…If the device is applied at the end of the procedure, the patient can be mobilised immediately without serious complications or longer examination times [19]. At our unit, we have used this device for a few years now, with similar results to those described in the literature.…”

Section: Discussionmentioning

confidence: 61%

“…Esso, applicato al termine della procedura, consente un'immediata mobilizzazione del paziente senza significative complicanze né allungamento dei tempi necessari all'esecuzione dell'esame [19]. Nella nostra Unità Clinico Operativa viene utilizzato già da qualche anno tale dispositivo con risultati comparabili a quelli riscontrabili in letteratura.…”

Section: Discussionunclassified

MR angiography versus intra-arterial digital subtraction angiography of the lower extremities: activity-based cost analysis

Stacul

Mucelli

Lubin³

et al. 2006

Radiol med

View full text Add to dashboard Cite

Intra-arterial DSA costs more than MRA, mainly because of the higher costs of supplies used during the procedure and higher personnel costs (as a result of the longer duration of intra-arterial DSA). It should be noted that our evaluation considers costs pertaining to the radiology department only. It is evident that an economic analysis considering hospital costs as well would result in much higher costs for DSA if post-procedure hospitalisation is required. Our results cannot be simply exported to other radiology departments since they refer to the technology and organisation adopted in our department. However, our cost analysis model can be easily applied to other environments. MRA provides good diagnostic accuracy in the evaluation of arteries of the lower extremities, and its biological cost is far lower than that of intra-arterial DSA (MRA is noninvasive, it does not use ionising radiation, and the contrast medium is safe). Its lower cost is another argument in favour of the use of MRA instead of intra-arterial DSA in the evaluation of lower-extremity arterial disease.

show abstract